Cargando…
Clozapine-induced myocarditis
Approved in 1989 for the management of treatment-resistant schizophrenia, Clozapine is a last-line atypical antipsychotic drug used with increasing frequency. In addition to its well-known side effect of agranulocytosis, this drug also carries with it rare but serious adverse cardiovascular risk of...
Autores principales: | Datta, Tanuka, Solomon, Allen J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761502/ https://www.ncbi.nlm.nih.gov/pubmed/29345690 http://dx.doi.org/10.1093/omcr/omx080 |
Ejemplares similares
-
Clozapine-induced myocarditis in an adolescent male with DiGeorge Syndrome
por: Ruhe, Ann Marie, et al.
Publicado: (2018) -
Clozapine-Induced Myocarditis: Is Mandatory Monitoring Warranted for Its Early Recognition?
por: Munshi, T. A., et al.
Publicado: (2014) -
Lessons Learned and Questions Raised by an Atypical Case of Clozapine-Induced Myocarditis
por: Earnshaw, Charles H., et al.
Publicado: (2016) -
Clozapine-induced hypersensitivity myocarditis presenting as sudden cardiac death
por: Katta, Natraj, et al.
Publicado: (2016) -
Percutaneous management of ostial stenosis of the left internal mammary artery graft
por: Datta, Tanuka, et al.
Publicado: (2018)